Healthcare · Medical - Devices
Price
$3.06
Market Cap
$15.3M
Employees
13
Beta
2.48
Avg Volume
556,724
CEO
Hyunsu Jung
Business Description
Operating from the United States, Hyperion DeFi, Inc. is a company undergoing a significant shift from its foundational work in ophthalmic drug-delivery, known as Optejet. Its current trajectory involves establishing itself as the inaugural U.S. firm on Nasdaq to hold a cryptocurrency treasury, predominantly denominated in HYPE tokens originating from the Hyperliquid blockchain. Furthermore, Hyperion DeFi oversees the "Kinetiq × Hyperion" validator, persists with its decentralized finance (DeFi) staking strategies, and continues to advance its Optejet UFD™ technology for ocular health.
Business History
Price Overview
Last updated: Jun 27, 2026 9:06am (just now)$3.06
+0.10 (+3.38%)
Day Range
$2.84 – $3.17
52-Week Range
$2.49 – $17.18
50-Day MA
$3.60
200-Day MA
$4.78
Volume
667,565.00
Analyst Price Targets
Low
$4.00
Consensus
$5.88
High
$7.75
(2 analysts)
Share Structure
Outstanding
4,990,521.00
Float
2,336,679.00
Free Float
46.8%
Moderate free float
— 46.8% of shares trade freely, ~53.2% held by insiders/institutions
Reasonable but insiders still hold a significant stake. This can be positive (skin in the game) but may limit liquidity during sell-offs.
Small absolute float (2.3M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-0.33
Stock Price: $3.06
EPS (Diluted): -9.40
EPS (Diluted): -9.40
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
0.43
Stock Price: $3.06
Total Equity: $41.06M
Shares: 5,000,331
Total Equity: $41.06M
Shares: 5,000,331
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-0.53
Market Cap: $15.27M
Total Debt: $7.80M
Cash: $6.44M
EBITDA: -$43.76M
Total Debt: $7.80M
Cash: $6.44M
EBITDA: -$43.76M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$19.9M
Market Cap: $15.27M
Total Debt: $7.80M
Cash: $6.44M
Total Debt: $7.80M
Cash: $6.44M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
21.88
Stock Price: $3.06
Revenue: $813,455
Shares: 5,000,331
Revenue: $813,455
Shares: 5,000,331
EV/Sales (Total value vs revenue — works when P/E can't)
API24.43
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
62.7%
Gross Profit: $510,165
Revenue: $813,455
Revenue: $813,455
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-2,333.4%
Operating Income: -$18.98M
Revenue: $813,455
Revenue: $813,455
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-5,570.6%
Net Income: -$45.31M
Revenue: $813,455
Revenue: $813,455
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-63.5%
Net Income: -$45.31M
Total Equity: $41.06M
Total Equity: $41.06M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-31.1%
Operating Income: -$18.98M
Tax Rate: 0.0%
Equity: $41.06M
Total Debt: $7.80M
Cash: $6.44M
Tax Rate: 0.0%
Equity: $41.06M
Total Debt: $7.80M
Cash: $6.44M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
2.68
Current Assets: $7.25M
Current Liabilities: $2.70M
Current Liabilities: $2.70M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.19
Short-Term Debt: $0.00
Long-Term Debt: $7.80M
Total Debt: $7.80M
Total Equity: $41.06M
Long-Term Debt: $7.80M
Total Debt: $7.80M
Total Equity: $41.06M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$0.16
Revenue: $813,455
Shares: 5,000,331
Shares: 5,000,331
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$8.21
Total Equity: $41.06M
Shares: 5,000,331
Shares: 5,000,331
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-2.95
Operating CF: -$14.77M
CapEx: $4.00
Shares: 5,000,331
CapEx: $4.00
Shares: 5,000,331
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
5.0%
Last Dividend: N/A
Stock Price: $3.06
Stock Price: $3.06
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$45.31M
Net Income: -$45.31M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares HYPD against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 21, 2026 8:46am (6d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $14.0M | $0 | $3,787 | $57,336 | $813,455 |
| Cost of Revenue | $1.6M | $0 | $16,005 | $3.9M | $303,290 |
| Gross Profit | $12.4M | $0 | $-12,218 | -$3.9M | $510,165 |
| Operating Expenses | $25.4M | $26.9M | $25.4M | $44.9M | $19.5M |
| Operating Income | -$13.0M | -$26.9M | -$25.4M | -$48.7M | -$19.0M |
| Net Income | -$12.8M | -$28.0M | -$27.3M | -$49.8M | -$45.3M |
| EBITDA | -$12.2M | -$26.3M | -$24.1M | -$46.2M | -$43.8M |
| EPS | $-39.20 | $-66.40 | $-53.15 | $-59.81 | $-9.40 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 21, 2026 8:46am (6d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $19.5M | $22.9M | $14.8M | $2.1M | $6.4M |
| Total Current Assets | $22.0M | $27.6M | $20.7M | $2.8M | $7.2M |
| Total Assets | $31.7M | $31.0M | $28.8M | $3.7M | $51.8M |
| Current Liabilities | $11.2M | $4.5M | $9.5M | $16.0M | $2.7M |
| Long-Term Debt | $0 | $8.4M | $9.0M | $0 | $7.8M |
| Total Liabilities | $11.2M | $13.8M | $19.8M | $16.8M | $10.7M |
| Total Equity | $20.5M | $17.2M | $9.0M | -$13.1M | $41.1M |
| Retained Earnings | -$90.2M | -$118.2M | -$145.5M | -$195.3M | -$240.6M |
Cash Flow (Annual)
Last updated: Jun 21, 2026 8:46am (6d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$20.9M | -$25.1M | -$23.8M | -$30.1M | -$14.8M |
| Capital Expenditure | -$1.6M | $-874,745 | -$4.0M | $-161,477 | $4 |
| Free Cash Flow | -$22.5M | -$26.0M | -$27.8M | -$30.3M | -$14.8M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$1.0M | -$4.5M | -$8.0M | -$12.7M | $4.3M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 9:06am (just now)| Metric | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| Revenue |
$7.1M $5.8M – $8.4M
|
$15.8M $12.9M – $18.7M
|
$42.0M $34.3M – $49.7M
|
$63.9M $52.2M – $75.6M
|
| EBITDA |
-$4.1M -$4.8M – -$3.3M
|
-$9.1M -$10.7M – -$7.4M
|
-$24.1M -$28.5M – -$19.7M
|
-$36.7M -$43.4M – -$30.0M
|
| Net Income |
$4.0M $3.0M – $4.9M
|
$2.2M $1.7M – $2.8M
|
-$21.1M -$26.1M – -$16.0M
|
$7.0M $5.3M – $8.7M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 21, 2026 8:46am (6d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | -100.0% | — | +1,414.0% | +1,318.8% |
| Gross Profit Growth | -100.0% | — | -31,573.7% | +113.2% |
| Operating Income Growth | -106.7% | +5.6% | -91.8% | +61.1% |
| Net Income Growth | -119.2% | +2.7% | -82.7% | +9.0% |
| EBITDA Growth | -116.3% | +8.4% | -91.7% | +5.3% |
Insider Trading (Recent)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-02 | Jung Hyunsu | P-Purchase | 500.00 | $3.68 | $1,840 |
| 2026-06-02 | Jung Hyunsu | P-Purchase | 500.00 | $3.64 | $1,820 |
| 2026-06-01 | Jung Hyunsu | P-Purchase | 2,000.00 | $3.81 | $7,620 |
| 2026-06-01 | Jung Hyunsu | P-Purchase | 5,000.00 | $3.66 | $18,300 |
| 2026-05-27 | Jung Hyunsu | F-InKind | 40,000.00 | $0.00 | $0 |
| 2026-03-30 | Knox David R. | F-InKind | 20,831.00 | $0.00 | $0 |
| 2026-01-12 | Rubenstein Robert | A-Award | 75,000.00 | $0.00 | $0 |
| 2026-01-12 | Rubenstein Robert | 0.00 | $0.00 | $0 | |
| 2025-12-31 | Knox David R. | P-Purchase | 27,950.00 | $3.59 | $100,341 |
| 2025-12-29 | Strahlman Ellen R | P-Purchase | 12,112.00 | $3.60 | $43,603 |
| 2025-12-26 | Strahlman Ellen R | P-Purchase | 3,601.00 | $3.86 | $13,911 |
| 2025-12-29 | Strahlman Ellen R | P-Purchase | 11,856.00 | $3.61 | $42,800 |
| 2025-12-26 | Strahlman Ellen R | P-Purchase | 3,311.00 | $3.86 | $12,777 |
| 2025-12-29 | Jung Hyunsu | F-InKind | 82,324.00 | $0.00 | $0 |
| 2025-12-18 | Strahlman Ellen R | P-Purchase | 19,702.00 | $3.14 | $61,835 |
| 2025-12-18 | Strahlman Ellen R | P-Purchase | 18,742.00 | $3.14 | $58,829 |
| 2025-12-17 | Walters Happy David | P-Purchase | 61,930.00 | $3.02 | $187,152 |
| 2025-12-17 | GELTZEILER MICHAEL S | P-Purchase | 30,000.00 | $3.01 | $90,210 |
| 2025-09-29 | Knox David R. | A-Award | 200,000.00 | $0.00 | $0 |
| 2025-09-29 | Knox David R. | A-Award | 100,000.00 | $0.00 | $0 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for HYPD — it's generated by the pipeline (
market-narrative step).
No community reviews yet for HYPD.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30